|
DralserpDrug - Dralserp The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Hydralazine Hydrochloride; Reserpine
Strength -
25MG;0.1MG
Applicant -
SANDOZ
New Drug Application (NDA) Number -
084617
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Sandoz Inc
Dralserp
Ser-a-gen 25mg;15mg;0.1mg Tablet; Oral
Ser-ap-es 25mg;15mg;0.1mg Tablet; Oral Unipres 25mg;15mg;0.1mg Tablet; Oral Unipres 25mg;15mg;0.1mg Tablet; Oral Bidil 37.5mg;20mg Tablet; Oral Dralserp 25mg;0.1mg Tablet; Oral Reserpine, Hydralazine Hcl And Hydrochlorothiazide 25mg;15mg;0.1mg Tablet; Oral Reserpine, Hydralazine Hcl And Hydrochlorothiazide 25mg;15mg;0.1mg Tablet; Oral Reserpine, Hydralazine Hcl And Hydrochlorothiazide 25mg;15mg;0.1mg Tablet; Oral Reserpine, Hydrochlorothiazide, And Hydralazine Hcl 25mg;15mg;0.1mg Tablet; Oral NewDrugInformation |